AI-Powered Literature Monitoring in Drug Safety
Update: 2025-09-03
Description
In this episode 14, host Julia Appelskog talks with Artem Horilyk from DrugCard about the role of artificial intelligence in literature screening for pharmacovigilance.
Together, they explore what AI tools can already do effectively, where the limitations remain, and what developments are on the horizon.
The discussion offers practical insights for pharmacovigilance professionals, highlighting both opportunities and challenges in adopting AI for drug safety monitoring.
Host: Julia Appelskog
Guest: Artem Horilyk, DrugCard
Subtitle:
What works, what doesn’t, and what’s coming
Links: https://drug-card.io/
LinkedIn: https://www.linkedin.com/in/artem-horilyk/
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
